MCN offers an 11.7% yield and defensive equity exposure, but structural issues and weak long-term performance limit upside.

During the third quarter of 2025, the Patient Opportunity Equity Strategy generated a total return of 14.1% net of fees. Read ...

In this series on portfolio basics, I’ll explain some of the fundamentals of putting together sound portfolios. I’ll start with some of the most widely used types of investments and walk through what ...

Investors love dividend stocks, especially those with ultra-high yields, because they offer a significant income stream and ...

This ETF focuses on high-performing stocks. Dividend-paying stocks don't get the credit they deserve. Over the past 50 years, the average dividend-paying stock in the S&P 500 has outperformed ...

2024 has been quite the year thus far — especially for income-focused investors. It has never been harder for income-focused investors to balance perceived risk with long-term gains. In this post, I ...

Asset managers selling private assets to everyday investors claim to have found investing’s holy grail: lower risk (or at least less volatility) and better returns. Is that true? The answer is mixed.

THURSDAY UPDATE: The SDRS return provided at the South Dakota Investment Council meeting on Thursday morning was that, through the market close on Wednesday, April 9, 2025, the SDRS total fund ...

The 60/20/20 portfolio is gaining after gold, bitcoin record runs, with alternatives taking half of bonds' former hold over a classic investor market approach.

The fund invests exclusively in securities listed on the Singapore Exchange (SGX) across large-, mid- and small-cap stocks, ...